PTCT — PTC THERAPEUTICS INC

Ownership history in EntryPoint Capital, LLC  ·  6 quarters on record

This page tracks every 13F SEC filing in which EntryPoint Capital, LLC reported a position in PTC THERAPEUTICS INC (PTCT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.19% (2024 Q3)
Avg. % of fund
0.15%
First filed
2023 Q4
Last filed
2025 Q3
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 7,384 +574 +8.4% 0.18% $453K $61.37
2025 Q2 REDUCED 6,810 -2,026 -22.9% 0.17% $333K $48.84
2024 Q3 ADDED 8,836 +4,781 +117.9% 0.19% $328K $37.10
2024 Q2 ADDED 4,055 +1,794 +79.3% 0.18% $124K $30.58
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    PTCT price (monthly, adj. close)

Other funds also holding PTCT

As of 2025 Q4 — sorted by position size

Palo Alto Investors LP 3Y 7Y 9.56% RTW INVESTMENTS, LP 3Y 7Y 5.89% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 5.63% MPM BioImpact LLC 3Y 3.74% ARMISTICE CAPITAL, LLC 3Y 7Y 2.53% Parkman Healthcare Partners LLC 3Y 1.16% SECTOR GAMMA AS 3Y 7Y 1.07% Hood River Capital Management LLC 3Y 7Y 0.84% Abacus FCF Advisors LLC 3Y 7Y 0.75% Ikarian Capital, LLC 3Y 0.7%
← Back to EntryPoint Capital, LLC Holdings